UBS Group’s Curis CRIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39 | Sell |
4
-181
| -98% | -$3.37K | ﹤0.01% | 10229 |
|
|
2025
Q4 | $3.65K | Buy |
185
+165
| +825% | +$4.43K | ﹤0.01% | 8977 |
|
|
2025
Q3 | $667 | Sell |
20
-66
| -77% | -$2.29K | ﹤0.01% | 9579 |
|
|
2025
Q2 | $3.98K | Buy |
86
+67
| +353% | +$2.63K | ﹤0.01% | 9302 |
|
|
2025
Q1 | $815 | Sell |
19
-1
| -5% | -$62 | ﹤0.01% | 9651 |
|
|
2024
Q4 | $1.22K | Buy |
20
+18
| +900% | +$1.54K | ﹤0.01% | 9285 |
|
|
2024
Q3 | $226 | Sell |
2
-90
| -98% | -$10.1K | ﹤0.01% | 9049 |
|
|
2024
Q2 | $12.7K | Buy |
92
+36
| +64% | +$8.96K | ﹤0.01% | 7584 |
|
|
2024
Q1 | $12.1K | Buy |
56
+42
| +300% | +$9.03K | ﹤0.01% | 7153 |
|
|
2023
Q4 | $3.6K | Sell |
14
-144
| -91% | -$23K | ﹤0.01% | 7949 |
|
|
2023
Q3 | $20.9K | Buy |
158
+156
| +7,800% | +$40.2K | ﹤0.01% | 6782 |
|
|
2023
Q2 | $699 | Sell |
2
-8
| -80% | -$2.6K | ﹤0.01% | 8127 |
|
|
2023
Q1 | $2.38K | Buy |
10
+4
| +67% | +$1.05K | ﹤0.01% | 8523 |
|
|
2022
Q4 | $1.31K | Sell |
6
-122
| -95% | -$35.8K | ﹤0.01% | 9899 |
|
|
2022
Q3 | $36K | Buy |
128
+83
| +184% | +$33.5K | ﹤0.01% | 6656 |
|
|
2022
Q2 | $18K | Buy |
45
+40
| +800% | +$16.7K | ﹤0.01% | 6996 |
|
|
2022
Q1 | $6K | Sell |
5
-1,226
| -100% | -$1.57M | ﹤0.01% | 8958 |
|
|
2021
Q4 | $2.34M | Buy |
1,231
+341
| +38% | +$811K | ﹤0.01% | 3586 |
|
|
2021
Q3 | $2.79M | Buy |
890
+884
| +14,733% | +$2.76M | ﹤0.01% | 3269 |
|
|
2021
Q2 | $19K | Sell |
6
-320
| -98% | -$1.45M | ﹤0.01% | 7377 |
|
|
2021
Q1 | $1.48M | Buy |
326
+321
| +6,420% | +$1.34M | ﹤0.01% | 3864 |
|
|
2020
Q4 | $16K | Buy |
5
+1
| +25% | +$1.2K | ﹤0.01% | 7100 |
|
|
2020
Q3 | $2K | Sell |
4
-13
| -76% | -$6.13K | ﹤0.01% | 7642 |
|
|
2020
Q2 | $9K | Sell |
17
-2
| -11% | -$738 | ﹤0.01% | 7068 |
|
|
2020
Q1 | $5K | Buy |
19
+8
| +73% | +$4.25K | ﹤0.01% | 7278 |
|
|
2019
Q4 | $7K | Sell |
11
-8
| -42% | -$5.8K | ﹤0.01% | 7440 |
|
|
2019
Q3 | $17K | Buy |
19
+10
| +111% | +$8.47K | ﹤0.01% | 6826 |
|
|
2019
Q2 | $7K | Sell |
9
-11
| -55% | -$7.71K | ﹤0.01% | 7232 |
|
|
2019
Q1 | $16K | Buy |
20
+8
| +67% | +$3.83K | ﹤0.01% | 6480 |
|
|
2018
Q4 | $3K | Buy |
12
+6
| +100% | +$3.28K | ﹤0.01% | 7707 |
|
|
2018
Q3 | $5K | Sell |
6
-7
| -54% | -$4.56K | ﹤0.01% | 7476 |
|
|
2018
Q2 | $9K | Buy |
13
+7
| +117% | +$7.17K | ﹤0.01% | 7183 |
|
|
2018
Q1 | $8K | Sell |
6
-16
| -73% | -$21K | ﹤0.01% | 6997 |
|
|
2017
Q4 | $30K | Buy |
22
+16
| +267% | +$37.6K | ﹤0.01% | 6230 |
|
|
2017
Q3 | $19K | Hold |
6
| – | – | ﹤0.01% | 6485 |
|
|
2017
Q2 | $24K | Sell |
6
-2
| -25% | -$8.36K | ﹤0.01% | 6161 |
|
|
2017
Q1 | $45K | Buy |
8
+3
| +60% | +$16.7K | ﹤0.01% | 5595 |
|
|
2016
Q4 | $33K | Hold |
5
| – | – | ﹤0.01% | 6157 |
|
|
2016
Q3 | $28K | Sell |
5
-2
| -29% | -$7.33K | ﹤0.01% | 5996 |
|
|
2016
Q2 | $22K | Hold |
7
| – | – | ﹤0.01% | 6212 |
|
|
2016
Q1 | $23K | Hold |
7
| – | – | ﹤0.01% | 6086 |
|
|
2015
Q4 | $40K | Sell |
7
-1
| -13% | -$4.88K | ﹤0.01% | 6021 |
|
|
2015
Q3 | $31K | Sell |
8
-3
| -27% | -$17K | ﹤0.01% | 6250 |
|
|
2015
Q2 | $73K | Buy |
11
+4
| +57% | +$24K | ﹤0.01% | 5659 |
|
|
2015
Q1 | $32K | Sell |
7
-3
| -30% | -$14.5K | ﹤0.01% | 6481 |
|
|
2014
Q4 | $30K | Buy |
+10
| New | +$26.3K | ﹤0.01% | 7108 |
|
Other funds holding CRIS
BL
SCM
NCM
SFM
CCC
DIG
VCM
MCM
UBS Group's CRIS Position: Q1 2026 in Review
UBS Group reduced its Curis (CRIS) stake by 98% in Q1 2026, selling an estimated $3.37K and leaving 4 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #10229.
UBS Group first reported a position in CRIS in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.79M in Q3 2021. 39 funds tracked by Wall St. Rank hold CRIS as of Q1 2026.
- UBS Group held 4 shares of Curis worth $39 as of Q1 2026.
- UBS Group sold 181 Curis shares in Q1 2026, an estimated $3.37K.
- Curis made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10229 holding.
- UBS Group first reported a position in Curis in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Curis position peaked at $2.79M in Q3 2021.
- 39 funds tracked by Wall St. Rank held Curis as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.